Area of research
Immunology · Dermatology
Research interest
Research interests include Medicine, Roflumilast, Psoriasis, Atopic dermatitis, Eczema Area and Severity Index, and Discontinuation.
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial
Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( <scp>INTEGUMENT</scp> ‐ <scp>PED</scp> ): A Phase 3 Randomized Controlled Trial
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score